Managers / Q1 2024 · view latest →
KENNEDY LEWIS MANAGEMENT LP
CIK 0001797633 · 225 LIBERTY STREET, SUITE 4210, NEW YORK, NY, 10281 · 212-782-3480
Summary
Kennedy Lewis Management LP reported $23M in U.S.-listed holdings across 8 positions for Q1 2024.
The portfolio is heavily concentrated: KODK alone accounts for 78.9% of reported value.
Compared with Q4 2023, the fund opened 3 new positions and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 99.6% · $23M
- Equity WRT · 0.3% · $57,805
- Other · 0.1% · $23,245
Quarter-over-Quarter Changes full breakdown →
vs Q4 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| FBYDWFALCONS BEYOND GLOBAL INC | NEW | +54.2K | 54.2K | +$38,594 | $38,594 |
| AMERICAN ONCOLOGY NETWORK IN | NEW | +50.0K | 50.0K | +$17,005 | $17,005 |
| SOLID POWER INC | NEW | +10.9K | 10.9K | +$2,206 | $2,206 |
| RCF ACQUISITION CORP | TRIMMED | −88.2K | 61.8K | −$4,196 | $3,319 |
| KODKEASTMAN KODAK CO | HELD | +0 | 3.68M | +$4M | $18M |
| RPIDRAPID MICRO BIOSYSTEMS INC | HELD | +0 | 4.94M | +$1M | $5M |
| CHURCHILL CAPITAL CORP VII | HELD | +0 | 40.3K | +$7,656 | $12,902 |
| POLESTAR AUTOMOTIVE HLDG UK | HELD | +0 | 40.0K | −$2,581 | $7,024 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2024
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | KODKEASTMAN KODAK COhistory → | COM NEW | 78.92% | $18M | 3.68M |
| 2 | RPIDRAPID MICRO BIOSYSTEMS INChistory → | CLASS A COM | 20.73% | $5M | 4.94M |
| 3 | FBYDWFALCONS BEYOND GLOBAL INC | *W EXP 03/16/202 | 0.17% | $38,594 | 54.2K |
| 4 | AMERICAN ONCOLOGY NETWORK IN | *W EXP 09/20/202 | 0.07% | $17,005 | 50.0K |
| 5 | CHURCHILL CAPITAL CORP VII | *W EXP 02/29/202 | 0.06% | $12,902 | 40.3K |
| 6 | POLESTAR AUTOMOTIVE HLDG UK | ADS C-1 | 0.03% | $7,024 | 40.0K |
| 7 | RCF ACQUISITION CORP | *W EXP 99/99/999 | 0.01% | $3,319 | 61.8K |
| 8 | SOLID POWER INC | *W EXP 12/08/202 | 0.01% | $2,206 | 10.9K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2024 | $22M | 6 | Oct 18, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $23M | 7 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $23M | 8 | Apr 30, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $18M | 5 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $21M | 7 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $29M | 11 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $38M | 12 | May 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $66M | 15 | Feb 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $88M | 20 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $91M | 20 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $161M | 20 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $150M | 29 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.